Literature DB >> 17937437

Cartilage hair hypoplasia mutations that lead to RMRP promoter inefficiency or RNA transcript instability.

Eiji Nakashima1, Joseph R Tran, Tim J M Welting, Ger J M Pruijn, Yuichiro Hirose, Gen Nishimura, Hirofumi Ohashi, Shepherd H Schurman, Jun Cheng, Fabio Candotti, Ramaiah Nagaraja, Shiro Ikegawa, David Schlessinger.   

Abstract

Cartilage hair hypoplasia (CHH; MIM 250250) is an autosomal recessive disease with diverse clinical manifestations. It is caused by mutations in RMRP gene, the RNA component of the ribonucleoprotein complex RNase MRP. Mutations in RMRP have been found in patients in the core promoter region or in the transcribed region, but the pathogenetic effect of the mutations is unclear. Real-time PCR assays confirmed that both promoter (c.-16_-1 dup and c.-15_+2 dup) and transcribed mutations (c.168G > A and c.218A > G) lower the expression level of RMRP. Experiments with 5'RACE, showed that the reduced transcription in the promoter mutants was accompanied by shifting of the transcription initiation sites to nucleotides 5'-upstream of the authentic site. Low levels of RMRP expression levels with transcript mutations were also seen when constructs encoding the wild-type and mutant genes were transfected into cultured cells. The reduced transcription was correlated with greater instability of mutant RMRP transcripts compared to controls. A comparable reduction was seen when a mouse gene containing the c.70A > G mutation (the major mutation in humans with CHH) was introduced into ES cells in place of one of the wild-type alleles. The low expression level of the c.70A > G Rmrp RNA was confirmed by expression assays into cultured cells, and was again correlated with RNA instability. Our results indicate that a loss of mutant RNA transcripts is a critical feature of pathogenesis. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17937437     DOI: 10.1002/ajmg.a.32053

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

Review 1.  Of proteins and RNA: the RNase P/MRP family.

Authors:  Olga Esakova; Andrey S Krasilnikov
Journal:  RNA       Date:  2010-07-13       Impact factor: 4.942

Review 2.  When ribosomes go bad: diseases of ribosome biogenesis.

Authors:  Emily F Freed; Franziska Bleichert; Laura M Dutca; Susan J Baserga
Journal:  Mol Biosyst       Date:  2010-01-11

3.  Quality control of assembly-defective U1 snRNAs by decapping and 5'-to-3' exonucleolytic digestion.

Authors:  Siddharth Shukla; Roy Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

Review 4.  Hypo- and Hyper-Assembly Diseases of RNA-Protein Complexes.

Authors:  Siddharth Shukla; Roy Parker
Journal:  Trends Mol Med       Date:  2016-06-03       Impact factor: 11.951

5.  RMRP is a non-coding RNA essential for early murine development.

Authors:  Joseph Rosenbluh; Deepak Nijhawan; Zhao Chen; Kwok-Kin Wong; Kenkichi Masutomi; William C Hahn
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

6.  RNase MRP cleaves pre-tRNASer-Met in the tRNA maturation pathway.

Authors:  Yuichiro Saito; Jun Takeda; Kousuke Adachi; Yuko Nobe; Junya Kobayashi; Kouji Hirota; Douglas V Oliveira; Masato Taoka; Toshiaki Isobe
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 7.  How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies.

Authors:  Giulia Venturi; Lorenzo Montanaro
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

8.  Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.

Authors:  Patrick Riley; Dennis S Weiner; Bonnie Leighley; David Jonah; D Holmes Morton; Kevin A Strauss; Michael B Bober; Martin S Dicintio
Journal:  J Child Orthop       Date:  2015-03-13       Impact factor: 1.548

9.  Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells.

Authors:  Jinjoo Park; Sunjoo Jeong
Journal:  Oncotarget       Date:  2015-10-27

Review 10.  Ribosomopathies: New Therapeutic Perspectives.

Authors:  Emilien Orgebin; François Lamoureux; Bertrand Isidor; Céline Charrier; Benjamin Ory; Frédéric Lézot; Marc Baud'huin
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.